The release behavior of the encapsulated compounds showed that compared with AD/Hp-β-CD, the layer-by-layer-assembled AD/Hp-β-CD/WPI microcapsules exhibited better stability and could prolong the metabolic cycle of AD and achieve a sustained release effect. The gene discussed is HP; the disease is Alzheimer disease.